Analyst Recommendations

84.89 0.51(0.60%)09/13/2024
Biomarin Pharmaceutical Inc. (BMRN)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Overweight13
Sector Perform6
Buy4
Hold3
Outperform3
Neutral2

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades